VivoSim Labs, Inc. VIVS
0.22
(0.01)
(4.35%)
as of 25 Sep
- Market cap
- $3.9M
- P/E
- 0.0×
Follow VIVS
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (343.10%) | (294.75%) | (51.07%) | (36.91%) |
+8 more TTM periods Free account |
|
| (155.93%) | (125.64%) | (22.71%) | (24.12%) | ||
ROIC |
0.00% | 0.00% | (4,678.92%) | (1,960.70%) | |
Return on Tangible Assets |
(810.64%) | (341.97%) | (32.17%) | (36.44%) | |
Average Days of Receivables |
3,405.58 | 2,914.43 | 2,683.52 | 83.43 | |
Free Cash Flow per Share |
(0.22) | (4.18) | (4.07) | (3.90) | |
Free Cash Flow |
(1.14) | (10.83) | (10.62) | (10.15) | |
Capital Expenditures |
8.96 | — | — | — | |
Piotroski F-Score |
3.00 | 2.00 | 4.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
1,494.08% | (275.85%) | (121.71%) | (73.89%) | |
Accounts Receivable Turnover |
0.21 | 0.24 | 0.27 | 4.59 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
3,857.14% | 3,197.71% | 2,762.68% | 3,259.29% | |
Selling, General and Administrative Expense of Revenue |
6,359.82% | 5,670.99% | 5,403.52% | 5,533.57% | |
Share Based Compensation of Revenue |
282.14% | 231.30% | 216.90% | 265.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.82 | 0.78 | 8.66 | 5.12 | |
Depreciation/Fixed assets |
1.03 | 1.04 | 0.94 | 0.83 | |
Capex/Depreciation |
46.21 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.02 | 0.05 | 0.05 | 0.05 | |
Operating CF per Share |
(1.93) | (4.18) | (4.07) | (3.90) | |
Capex per Share |
1.71 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
(80.04) | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(11,016.07%) | (10,567.18%) | (864.08%) | (1,416.43%) |
Columns are period end dates